Assort Health Raises $120M Series C to Scale AI Agents for the Patient Journey

Assort Health today raised $120 million in Series C funding led by Menlo Ventures. The Series C round values the company at $1.2 billion.

Assort Health builds AI agents for the patient journey.

With this round, Assort has now raised more than $222 million.

This funding round says a lot about where healthcare AI is heading right now. Patient access, scheduling, calls, follow-ups, and care navigation are becoming core areas where health systems want AI to take real work off the system.

Assort is now pushing to become the standard AI agents platform for healthcare organizations working on the patient journey.

Assort also announced a major expansion into health system operations, bringing the platform behind the largest AI-powered patient access deployment among provider groups to health systems ranging from large community-based organizations to academic medical centers. Several health systems, such as John Muir Health, are partnering with Assort as demand grows for platforms that can support increasingly complex ambulatory operations.

In addition to Menlo Ventures, investors participating in this latest round include Lightspeed Venture Partners, Felicis, First Round Capital, Chemistry, Joe Montana, Tau Ventures, and Quiet Capital.

JP Sanday, partner at Menlo Ventures, will join Assort’s Board, and fellow partner Matt Murphy, will serve as a Board Observer.